FDA Drug Application (021717) for PLIAGLIS by GALDERMA LABS LP

Back to FDA Applications sponsored by GALDERMA LABS LP

Application Number021717
Product Number001
FormCREAM;TOPICAL
Dosage7%;7%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePLIAGLIS
Active IngredientLIDOCAINE; TETRACAINE

Active IngredientCount
List of drugs with Active Ingredient LIDOCAINE12
List of drugs with Active Ingredient TETRACAINE2


Back to FDA Applications sponsored by GALDERMA LABS LP